Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance

Go back to Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance

Tandem Diabetes (TNDM) Misses Q2 EPS by 5c; Guides FY Revenue Below Views

August 3, 2023 4:23 PM EDT

(Updated - August 3, 2023 5:46 PM EDT)

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.55), $0.05 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $198.2 million versus the consensus estimate of $197.62 million.

GUIDANCE:

Tandem Diabetes sees FY2023... More